Working Together to Understand, Protect and Restore Vision
Gillian McLellan (Ophthalmology) is shown here checking out the eyes of a rare human/Mustelidae hybrid at a Badger hockey game in November. The creature, fully recovered, later posed with McPherson ERI Director David Gamm.
In a study released today, researchers from a variety of institutions – including the Marshfield Clinic, whose director, Dr. Murray Brilliant, is the lead author of the study – have announced that patients who use the drug L-DOPA, commonly used for Parkinson’s Disease and other movement disorders, are “significantly less likely to develop Age-related Macular …
7th Annual Vision Science Poster Session & Lecture Tuesday, November 3rd, 2015; HSLC Atrium Professors Susana Martinez-Conde & Stephen Macknik State University of New York (SUNY) Downstate Medical Center, Laboratory of Integrative Neuroscience Sleights of Mind: What the Neuroscience of Magic Reveals About our Everyday Deceptions
A New Study from McPherson ERI Members & Collaborators Shows That Patients Taking the Drug L-DOPA are Significantly Less Likely to Develop Age-related Macular Degeneration (AMD). Read more
Guest Lecturers Bring Neuromagic to the HSLC McPherson ERI’s annual event showcasing vision-related research was held on Tuesday, November 3rd, drawing more than 100 participants to the atrium of the Health Sciences Learning Center. Following the poster session, Drs. Susana Martinez-Conde and Stephen Macknik (Professors at SUNY Downstate Medical Center in New York City and …